Top Story

Tue 3:55 pm

Wall Street breaks 5-day losing run as investors look for tomorrow’s Fed statement

U.S. stocks halted the five-day losing streak today, as investors looked past softer economic reports and a continued rout in China’s stock market, and waited for the outcome of the two-day Federal Reserve. The S&P 500 (INDEXSP:.INX) rose 1.3 percent to 2,093.59 at 3.45 p.m. in New York. The 30-company Dow Jones Industrial Average (INDEXDJX:.DJI) added 1.1 percent to 17,631.10, while the tech-heavy Nasdaq Composite (INDEXNASDAQ:.IXIC) added 1 percent to 5,088.11. 

Breaking News

Tuesday, July 28, 3:45 pm

Baidu sinks on Wall Street after posting 2nd quarter results

Baidu (NASDAQ:BIDU) was trading over 17% lower today after the NASDAQ listed Chinese search engine after releasing quarterly results that were much lower than analysts' expectations. On Monday ...

International

6:34 am

Legendary Investments boss on growth sector opportunities

The executive chairman of Legendary Investments (LON:LEG), Zafar Karim, discusses the company’s investment approach and where he sees opportunity among in the small cap sector. AIM-listed Legendary makes invest...

Articles

  • TSX halts 7-day rout as China fears abate; Husky, MEG gain

    Canadian shares broke a seven-day rout as investors assessed earnings reports and as Chinese shares pulled back from a selloff. The Standard & Poor’s/TSX Composite Index (TSE:OSPTX) rose 0.4 percent to 14,053.12 at 12:50 p.m. in Toronto. Three shares advanced for every issue that declined as six out of ten share groups were in the positive territory.

  • Lawsuits and tough competition are driving American Apparel toward bankruptcy

    The stock price has lost over 20% in the past 24 hours as ‘The New Yorker’ asked in an article published on July 27 whether the company could afford to maintain its production in the United States

  • Teva to buy Allergan for $40.5 bln, drops Mylan bid

    Teva Pharmaceutical Industries (NYSE:TEVA), an Israeli drugmaker, agreed to buy Dublin-based Allergan PLC's (NYSE:AGN) generic pharmaceuticals business for $40.5 billion in cash and stock, and dropped its hostile offer for Mylan (NASDAQ:MYL). Teva will pay $33.75 billion in cash and $6.75 billion worth of shares at today’s price, or about 10 percent of the enlarged company, the Petach Tikva, Israel-based company said in a statement today. 

  • GlaxoSmithKline receives EU approval of its malaria fighting vaccine for children

    Approval from the EMA opens the door for a similarly favorable opinion from the World Health Organization (WHO), which could then decide whether to recommend vaccination in countries where malaria is endemic

  • Lithium – the metal of the future (if there's enough)

    Tesla is not alone in advancing lithium-powered battery technologies. 

    It’s headline-grabbing stuff - Elon Musk says that his Tesla Corporation (NASDAQ:TSLA) aims to accelerate technological and market development by up to ten years in the roll-out of electric cars.

  • Amazon.com swings to surprise Q2 profit, provides robust Q3 revenue guidance

    Amazon.com (NASDAQ:AMZN), an online retailer, reported an unexpected second-quarter profit, forecast third-quarter revenue above estimates, and reported strong sales in North America, and unprecedented growth in its popular Prime two-day unlimited shipping service. Shares surged.

Archived Top Stories ►
  • Energy Fuels emerging as the major US uranium player

    Curtis Moore, vice president of Energy Fuels (TSE:EFR) (NYSE:UUUU), says the company is emerging as the major uranium producer in the United...
    View full size
  • Gold facing ‘perfect storm’ says CMC Markets’ Cieszynski

    Colin Cieszynski, chief market strategist at CMC Markets, explains why he believes gold is facing a perfect storm in the current environment,...
    View full size
  • VolitionRX seeks to revolutionise cancer diagnosis Share

    New York-listed VolitionRx aims to revolutionise cancer screening, and its chief executive Cameron Reynolds explains to Proactive Investors...
    View full size
  • Greencastle Resources CEO outlines royalty strategy

    Tony Roodenburg, chief executive of Greencastle Resources (CVE:VGN), discusses the company’s strategy with Proactive Investors and explains...
    View full size
  • PDAC 2015 presentations: Endeavour Silver

    Terry Chandler, vice president of corporate development at Endeavour Silver (NYSE:EXK, TSE:EDR), explains his plans for the company at the...
    View full size
  • PDAC 2015 presentations: Arian Silver

    Jim Williams, chief executive of Arian Silver (LON:AGQ, CVE:AGQ), talks investors through the strategy at the PDAC Power Breakfast 2015.
    View full size
  • PDAC 2015 presentations: Largo Resources

    Mark Brennan, president, chief executive and director of Largo Resources (CVE:LGO), presents to investors at the PDAC Power Breakfast 2015.
    View full size
  • Canadian Overseas Petroleum CFO on ‘significant’ tie-up with Shoreline Energy

    Christopher McLean, the chief financial officer of Canadian Overseas Petroleum (LON:COPL), explains the benefits of teaming up with Shoreline...
    View full size
  • Mandalay Resources unveils positive Q4 figures

    Record production in its fourth quarter helped gold and silver miner Mandalay Resources (TSE:MND) lift fourth quarter profits despite weak...
    View full size
  • ANGLE CEO: Fully funded for Parsortix ovarian cancer care, new partnership with MD Anderson

    Andrew Newland, the chief executive of ANGLE plc (LON:AGL) spoke about the need for speed to progress the firm’s plans to revolutionise...
    View full size
  • Rathdowney Resources is the Next Zinc Producer in Europe

    Interview with Chairman & Director David Copeland
    View full size
  • Rathdowney Resources is Moving Straight Forward for the Permitting of the Olza Deposit

    Interview with President & CEO Robert Konski - Commodity TV
    View full size